Kin Health | $9,000,000 | (May 20, 2026)
Scope AI | $20,000,000 | (May 20, 2026)
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
Certified by Founder
Lodge
Trogenix
start up
United Kingdom
- Edinburgh, Scotland
- 07/10/2025
- Series A
- $94,323,600
Precision genetic medicines, engineered for change
- Industry Biotechnology Research
- Website https://trogenix.com/
- LinkedIn https://www.linkedin.com/company/trogenixbio/
Related People
Ken MacnamaraFounder
United Kingdom -
Greater Edinburgh Area
Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.
Hellbender Inc. | $12,500,000 | (May 20, 2026)
Rely | $4,500,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
viktor.com | $75,000,000 | (May 20, 2026)
Brami Inc. | $33,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)